These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 17635146

  • 1. Cell-penetrating-peptide-based delivery of oligonucleotides: an overview.
    Abes R, Arzumanov AA, Moulton HM, Abes S, Ivanova GD, Iversen PL, Gait MJ, Lebleu B.
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):775-9. PubMed ID: 17635146
    [Abstract] [Full Text] [Related]

  • 2. Peptide-based delivery of nucleic acids: design, mechanism of uptake and applications to splice-correcting oligonucleotides.
    Abes S, Moulton H, Turner J, Clair P, Richard JP, Iversen P, Gait MJ, Lebleu B.
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):53-5. PubMed ID: 17233600
    [Abstract] [Full Text] [Related]

  • 3. Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents.
    Abes S, Moulton HM, Clair P, Prevot P, Youngblood DS, Wu RP, Iversen PL, Lebleu B.
    J Control Release; 2006 Dec 01; 116(3):304-13. PubMed ID: 17097177
    [Abstract] [Full Text] [Related]

  • 4. Cell penetrating peptide conjugates of steric block oligonucleotides.
    Lebleu B, Moulton HM, Abes R, Ivanova GD, Abes S, Stein DA, Iversen PL, Arzumanov AA, Gait MJ.
    Adv Drug Deliv Rev; 2008 Mar 01; 60(4-5):517-29. PubMed ID: 18037527
    [Abstract] [Full Text] [Related]

  • 5. Arginine-rich cell penetrating peptides: design, structure-activity, and applications to alter pre-mRNA splicing by steric-block oligonucleotides.
    Abes R, Arzumanov A, Moulton H, Abes S, Ivanova G, Gait MJ, Iversen P, Lebleu B.
    J Pept Sci; 2008 Apr 01; 14(4):455-60. PubMed ID: 18236382
    [Abstract] [Full Text] [Related]

  • 6. Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure-activity studies.
    Abes R, Moulton HM, Clair P, Yang ST, Abes S, Melikov K, Prevot P, Youngblood DS, Iversen PL, Chernomordik LV, Lebleu B.
    Nucleic Acids Res; 2008 Nov 01; 36(20):6343-54. PubMed ID: 18796528
    [Abstract] [Full Text] [Related]

  • 7. Lipoplex and peptide-based strategies for the delivery of steric-block oligonucleotides.
    Resina S, Abes S, Turner JJ, Prevot P, Travo A, Clair P, Gait MJ, Thierry AR, Lebleu B.
    Int J Pharm; 2007 Nov 01; 344(1-2):96-102. PubMed ID: 17600642
    [Abstract] [Full Text] [Related]

  • 8. Cell-penetrating peptide-morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo.
    Moulton HM, Fletcher S, Neuman BW, McClorey G, Stein DA, Abes S, Wilton SD, Buchmeier MJ, Lebleu B, Iversen PL.
    Biochem Soc Trans; 2007 Aug 01; 35(Pt 4):826-8. PubMed ID: 17635157
    [Abstract] [Full Text] [Related]

  • 9. Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide.
    Abes S, Turner JJ, Ivanova GD, Owen D, Williams D, Arzumanov A, Clair P, Gait MJ, Lebleu B.
    Nucleic Acids Res; 2007 Aug 01; 35(13):4495-502. PubMed ID: 17584792
    [Abstract] [Full Text] [Related]

  • 10. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
    Youngblood DS, Hatlevig SA, Hassinger JN, Iversen PL, Moulton HM.
    Bioconjug Chem; 2007 Aug 01; 18(1):50-60. PubMed ID: 17226957
    [Abstract] [Full Text] [Related]

  • 11. Induction of splice correction by cell-penetrating peptide nucleic acids.
    El-Andaloussi S, Johansson HJ, Lundberg P, Langel U.
    J Gene Med; 2006 Oct 01; 8(10):1262-73. PubMed ID: 16900561
    [Abstract] [Full Text] [Related]

  • 12. Arginine-rich peptides and their internalization mechanisms.
    Futaki S, Nakase I, Tadokoro A, Takeuchi T, Jones AT.
    Biochem Soc Trans; 2007 Aug 01; 35(Pt 4):784-7. PubMed ID: 17635148
    [Abstract] [Full Text] [Related]

  • 13. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
    Reissmann S.
    J Pept Sci; 2014 Oct 01; 20(10):760-84. PubMed ID: 25112216
    [Abstract] [Full Text] [Related]

  • 14. Helix-Stabilized Cell-Penetrating Peptides for Delivery of Antisense Morpholino Oligomers: Relationships among Helicity, Cellular Uptake, and Antisense Activity.
    Takada H, Tsuchiya K, Demizu Y.
    Bioconjug Chem; 2022 Jul 20; 33(7):1311-1318. PubMed ID: 35737901
    [Abstract] [Full Text] [Related]

  • 15. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
    Nakase I, Akita H, Kogure K, Gräslund A, Langel U, Harashima H, Futaki S.
    Acc Chem Res; 2012 Jul 17; 45(7):1132-9. PubMed ID: 22208383
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The many futures for cell-penetrating peptides: how soon is now?
    Howl J, Nicholl ID, Jones S.
    Biochem Soc Trans; 2007 Aug 17; 35(Pt 4):767-9. PubMed ID: 17635144
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.